Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2018 2
2020 1
2021 8
2022 10
2023 14
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for athira one an
Search for Athita Onuean instead (1 results)
Lecanemab (BAN2401): an anti-beta-amyloid monoclonal antibody for the treatment of Alzheimer disease.
Vitek GE, Decourt B, Sabbagh MN. Vitek GE, et al. Expert Opin Investig Drugs. 2023 Feb;32(2):89-94. doi: 10.1080/13543784.2023.2178414. Epub 2023 Feb 28. Expert Opin Investig Drugs. 2023. PMID: 36749830 Free PMC article. Review.
The experience of aducanumab informs the development of other mAbs, such as lecanemab. One consideration is the conformation of Abeta targets. Targeting monomeric species has not resulted in robust clinical efficacy, whereas targeting Abeta in the form of oligomers, protof …
The experience of aducanumab informs the development of other mAbs, such as lecanemab. One consideration is the conformation of Abeta …
Results and insights from a phase I clinical trial of Lomecel-B for Alzheimer's disease.
Brody M, Agronin M, Herskowitz BJ, Bookheimer SY, Small GW, Hitchinson B, Ramdas K, Wishard T, McInerney KF, Vellas B, Sierra F, Jiang Z, Mcclain-Moss L, Perez C, Fuquay A, Rodriguez S, Hare JM, Oliva AA Jr, Baumel B. Brody M, et al. Alzheimers Dement. 2023 Jan;19(1):261-273. doi: 10.1002/alz.12651. Epub 2022 Mar 31. Alzheimers Dement. 2023. PMID: 35357079 Free PMC article. Clinical Trial.
Tilavonemab in early Alzheimer's disease: results from a phase 2, randomized, double-blind study.
Florian H, Wang D, Arnold SE, Boada M, Guo Q, Jin Z, Zheng H, Fisseha N, Kalluri HV, Rendenbach-Mueller B, Budur K, Gold M. Florian H, et al. Brain. 2023 Jun 1;146(6):2275-2284. doi: 10.1093/brain/awad024. Brain. 2023. PMID: 36730056 Free PMC article. Clinical Trial.
In this 96-week, randomized, double-blind, placebo-controlled study (NCT02880956), patients aged 55-85 years meeting clinical criteria for early Alzheimer's disease with a Clinical Dementia Rating-Global Score of 0.5, a Mini-Mental State Examination score of 22 to 30, a Repeatabl …
In this 96-week, randomized, double-blind, placebo-controlled study (NCT02880956), patients aged 55-85 years meeting clinical criteria for e …
One step forward to personalized medicine?
Dodge HH, Arnold SE. Dodge HH, et al. Alzheimers Dement (N Y). 2023 Nov 15;9(4):e12435. doi: 10.1002/trc2.12435. eCollection 2023 Oct-Dec. Alzheimers Dement (N Y). 2023. PMID: 38023621 Free PMC article. No abstract available.
Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical Trial.
Mintzer J, Lanctôt KL, Scherer RW, Rosenberg PB, Herrmann N, van Dyck CH, Padala PR, Brawman-Mintzer O, Porsteinsson AP, Lerner AJ, Craft S, Levey AI, Burke W, Perin J, Shade D; ADMET 2 Research Group. Mintzer J, et al. JAMA Neurol. 2021 Nov 1;78(11):1324-1332. doi: 10.1001/jamaneurol.2021.3356. JAMA Neurol. 2021. PMID: 34570180 Free PMC article. Clinical Trial.
IMPORTANCE: Apathy, characterized by diminished will or initiative and one of the most prevalent neuropsychiatric symptoms in individuals with Alzheimer disease, is associated with significant caregiver burden, excess disability, increased medical costs, and mortality. ...
IMPORTANCE: Apathy, characterized by diminished will or initiative and one of the most prevalent neuropsychiatric symptoms in individ …
ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer's Disease.
Krafft GA, Jerecic J, Siemers E, Cline EN. Krafft GA, et al. Front Neurosci. 2022 Apr 26;16:848215. doi: 10.3389/fnins.2022.848215. eCollection 2022. Front Neurosci. 2022. PMID: 35557606 Free PMC article. Review.
Approved treatments confer modest improvement in symptoms, and recently one treatment obtained accelerated approval from the United States Food and Drug Administration (FDA) and may have modest disease modifying benefit. ...Aducanumab (targeting amyloid plaques), which rec …
Approved treatments confer modest improvement in symptoms, and recently one treatment obtained accelerated approval from the United S …
A CBCT Study to Evaluate the Root and Canal Morphology of Permanent Maxillary First Molars in Children.
Krishnamurthy NH, Athira P, Umapathy T, Balaji P, Jose S. Krishnamurthy NH, et al. Int J Clin Pediatr Dent. 2022 Sep-Oct;15(5):509-513. doi: 10.5005/jp-journals-10005-2441. Int J Clin Pediatr Dent. 2022. PMID: 36865715 Free PMC article.
INTRODUCTION: For the correct diagnosis and endodontic therapy, a complete understanding of root canal morphology is required. One of the causes of endodontic failure is the inability to identify every canal in the root canal system; the second mesiobuccal canal (MB2) in t …
INTRODUCTION: For the correct diagnosis and endodontic therapy, a complete understanding of root canal morphology is required. One of …
Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit.
Sattler R, Traynor BJ, Robertson J, Van Den Bosch L, Barmada SJ, Svendsen CN, Disney MD, Gendron TF, Wong PC, Turner MR, Boxer A, Babu S, Benatar M, Kurnellas M, Rohrer JD, Donnelly CJ, Bustos LM, Van Keuren-Jensen K, Dacks PA, Sabbagh MN; Attendees of the inaugural C9ORF72 FTD/ALS Summit. Sattler R, et al. Neurol Ther. 2023 Dec;12(6):1821-1843. doi: 10.1007/s40120-023-00548-8. Epub 2023 Oct 17. Neurol Ther. 2023. PMID: 37847372 Free PMC article.
Some people who have the disease frontotemporal dementia or the disease amyotrophic lateral sclerosis have a change in one of their genes; the name of the gene is C9ORF72. People who carry this genetic difference usually inherited it from a parent. ...
Some people who have the disease frontotemporal dementia or the disease amyotrophic lateral sclerosis have a change in one of their g …
An Overview of the Heterogeneity of Major Depressive Disorder: Current Knowledge and Future Prospective.
Athira KV, Bandopadhyay S, Samudrala PK, Naidu VGM, Lahkar M, Chakravarty S. Athira KV, et al. Curr Neuropharmacol. 2020;18(3):168-187. doi: 10.2174/1570159X17666191001142934. Curr Neuropharmacol. 2020. PMID: 31573890 Free PMC article. Review.
Moreover, with the recent drastic rise in the pace of life, stress has materialized as one of the most potent environmental factors for depression. In this scenario, it is important to understand the modern pathogenetic hypotheses and mechanisms, and possibly try to shift …
Moreover, with the recent drastic rise in the pace of life, stress has materialized as one of the most potent environmental factors f …
Pyrogens, a polypeptide produces fever by metabolic changes in hypothalamus: Mechanisms and detections.
Prajitha N, Athira SS, Mohanan PV. Prajitha N, et al. Immunol Lett. 2018 Dec;204:38-46. doi: 10.1016/j.imlet.2018.10.006. Epub 2018 Oct 15. Immunol Lett. 2018. PMID: 30336182 Review.
Fever is one of the cardinal symptoms of onset of an infection or inflammation and is the common clinical indicator for medical consultation in mammalian host worldwide. ...
Fever is one of the cardinal symptoms of onset of an infection or inflammation and is the common clinical indicator for medical consu …
36 results